AU2001295672A1 - Vaccine composition and stabilisation method - Google Patents
Vaccine composition and stabilisation methodInfo
- Publication number
- AU2001295672A1 AU2001295672A1 AU2001295672A AU2001295672A AU2001295672A1 AU 2001295672 A1 AU2001295672 A1 AU 2001295672A1 AU 2001295672 A AU2001295672 A AU 2001295672A AU 2001295672 A AU2001295672 A AU 2001295672A AU 2001295672 A1 AU2001295672 A1 AU 2001295672A1
- Authority
- AU
- Australia
- Prior art keywords
- vaccine composition
- stabilisation method
- stabilisation
- vaccine
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003019 stabilising Effects 0.000 title 1
- 229960005486 vaccines Drugs 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0012805A FR2814957B1 (en) | 2000-10-06 | 2000-10-06 | VACCINE COMPOSITION AND STABILIZATION METHOD |
FR00/12805 | 2000-10-06 | ||
PCT/FR2001/003097 WO2002028362A2 (en) | 2000-10-06 | 2001-10-08 | Vaccine composition and stabilisation method |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001295672A1 true AU2001295672A1 (en) | 2002-06-27 |
AU2001295672B2 AU2001295672B2 (en) | 2005-08-18 |
Family
ID=8855080
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001295672A Ceased AU2001295672B2 (en) | 2000-10-06 | 2001-10-08 | Vaccine composition and stabilisation method |
AU9567201A Pending AU9567201A (en) | 2000-10-06 | 2001-10-08 | Vaccine composition and stabilisation method |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU9567201A Pending AU9567201A (en) | 2000-10-06 | 2001-10-08 | Vaccine composition and stabilisation method |
Country Status (12)
Country | Link |
---|---|
US (1) | US6982088B2 (en) |
EP (1) | EP1357895A2 (en) |
JP (1) | JP2004526667A (en) |
KR (1) | KR100832551B1 (en) |
CN (1) | CN1298387C (en) |
AU (2) | AU2001295672B2 (en) |
BR (1) | BR0114350A (en) |
CA (1) | CA2424863A1 (en) |
FR (1) | FR2814957B1 (en) |
MX (1) | MXPA03002875A (en) |
NZ (1) | NZ525117A (en) |
WO (1) | WO2002028362A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007056847A1 (en) * | 2005-11-21 | 2007-05-24 | Sanofi Pasteur Limited | Stabilizing formulations for recombinant viruses |
BR112013005049A2 (en) * | 2010-09-02 | 2016-05-31 | Sanofi Pasteur | stabilizer for the preparation of an injectable dry polio vaccine composition |
US10400029B2 (en) | 2011-06-28 | 2019-09-03 | Inhibrx, Lp | Serpin fusion polypeptides and methods of use thereof |
PL2726092T3 (en) | 2011-06-28 | 2019-11-29 | Inhibrx Lp | Serpin fusion polypeptides and methods of use thereof |
KR20140068861A (en) | 2011-06-28 | 2014-06-09 | 인히브릭스 엘엘씨 | Wap domain fusion polypeptides and methods of use thereof |
US9827303B2 (en) * | 2012-03-05 | 2017-11-28 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport | Methods and compositions for stabilizing dried biological materials |
SG11201507462QA (en) * | 2013-03-14 | 2015-10-29 | Takeda Vaccines Inc | Compositions and methods for live, attenuated alphavirus formulations |
NL2018155B1 (en) * | 2017-01-11 | 2018-07-25 | Intervet Int Bv | Oral vaccine against ruminant respiratory disease |
US20210322542A1 (en) * | 2020-04-11 | 2021-10-21 | Qiyi Xie | Vaccination against coronavirus with poliomyelitis vaccine |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617350C3 (en) * | 1967-06-22 | 1979-09-06 | Behringwerke Ag, 3550 Marburg | Process for the inactivation of biological material |
US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
US3915794A (en) * | 1973-02-09 | 1975-10-28 | Rit Rech Ind Therapeut | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them |
US3915764A (en) * | 1973-05-18 | 1975-10-28 | Westinghouse Electric Corp | Sputtering method for growth of thin uniform layers of epitaxial semiconductive materials doped with impurities |
ES2037072T3 (en) * | 1986-12-19 | 1993-06-16 | Duphar International Research B.V | STABILIZED COADJUVANT SUSPENSION INCLUDING DIMETHYL-DIOCTADECIL-AMMONIUM BROMIDE. |
US5709860A (en) * | 1991-07-25 | 1998-01-20 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
CA2075521C (en) * | 1992-05-05 | 1995-11-28 | Kuniaki Koyama | Stabilized live vaccine |
JP3583128B2 (en) * | 1993-01-08 | 2004-10-27 | シーエスエル、リミテッド | Vaccine preparation |
CA2158935A1 (en) * | 1993-10-12 | 1995-04-20 | Chiron Viagene, Inc. | Methods for preserving recombinant viruses |
US6379677B1 (en) * | 2000-02-25 | 2002-04-30 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Streptococcus iniae vaccine |
-
2000
- 2000-10-06 FR FR0012805A patent/FR2814957B1/en not_active Expired - Fee Related
-
2001
- 2001-10-08 CA CA002424863A patent/CA2424863A1/en not_active Abandoned
- 2001-10-08 MX MXPA03002875A patent/MXPA03002875A/en active IP Right Grant
- 2001-10-08 EP EP01976379A patent/EP1357895A2/en not_active Withdrawn
- 2001-10-08 CN CNB018169708A patent/CN1298387C/en not_active Expired - Fee Related
- 2001-10-08 AU AU2001295672A patent/AU2001295672B2/en not_active Ceased
- 2001-10-08 JP JP2002531988A patent/JP2004526667A/en active Pending
- 2001-10-08 WO PCT/FR2001/003097 patent/WO2002028362A2/en active IP Right Grant
- 2001-10-08 KR KR1020037004927A patent/KR100832551B1/en not_active IP Right Cessation
- 2001-10-08 AU AU9567201A patent/AU9567201A/en active Pending
- 2001-10-08 US US10/381,948 patent/US6982088B2/en not_active Expired - Fee Related
- 2001-10-08 BR BR0114350-6A patent/BR0114350A/en not_active IP Right Cessation
- 2001-10-08 NZ NZ525117A patent/NZ525117A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPQ879000A0 (en) | Mortar composition and method | |
AU2001249967A1 (en) | Composition and methods for tissue preservation | |
AU2001219651A1 (en) | Mulch composition and method | |
AUPR510001A0 (en) | Formulation and method | |
AU2001280599A1 (en) | Compounds and methods | |
AU2001253418A1 (en) | Compounds and methods | |
AU4163402A (en) | Composition and method | |
AU2001260774A1 (en) | Bio-support and preparing method of the same | |
AU2001243394A1 (en) | Compounds and methods | |
AU2001295672A1 (en) | Vaccine composition and stabilisation method | |
AU2001233932A1 (en) | Method and composition | |
AU9567201A (en) | Vaccine composition and stabilisation method | |
AUPQ872300A0 (en) | Compounds and methods | |
AU2001233086A1 (en) | Ceramidase compositions and methods based thereon | |
AU2001278951A1 (en) | Compounds and methods | |
AU2001261317A1 (en) | Immunostimulant compositions and associated methods | |
AU2001252741A1 (en) | Pharmaceutical composition containing itraconazole with gastric ph-independentlyimproved solubility and preparation method thereof | |
AU2001234616A1 (en) | Vaccine composition, process and methods | |
AU2002239775A1 (en) | Chemical-library composition and method | |
AU2002256556A1 (en) | Sea-trosy and related methods | |
AU2002235277A1 (en) | Compounds and methods | |
AU2001259564A1 (en) | Pharmaceutical compositions and methods for use | |
AU2001249194A1 (en) | Immunokine composition and method | |
AU2001253469A1 (en) | Compositions and methods for stabilizing modified tissue | |
AUPQ876400A0 (en) | Compositions and method of using them |